HSIRI THERAPEUTICS

Hsiri Therapeutics is advancing its portfolio though a variety of funding sources and is actively seeking partners in the development of its products... Hsiri Therapeutics is focused on discovering and developing therapies for infections due to drug resistant bacteria and drug resistant fungal diseases. Hsiri's research efforts are currently focused on three major areas - infections due to mycobacteria, infections due to usual bacterial pathogens that are resistant to currently prescribed treatments, and infections due to drug resistant fungal pathogens. The research concepts for all of Hsiri Therapeutics products originated from the research efforts of Professor Marvin Miller at the University of Notre Dame... The third area of focus for Hsiri is identifying and developing compounds effective against drug resistant fungal infections. Both topical and systemic fungal infections are becoming more drug resistant. Current approaches to treat systemic fungal lung infections are often to..

Also known as: Hsiri, Hsiri Therapeutics, Inc.

Primary location: Media United States